Literature DB >> 17341586

Determinants of 4 alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4.

Joris Vriens1, Grzegorz Owsianik, Annelies Janssens, Thomas Voets, Bernd Nilius.   

Abstract

TRPV4, a Ca(2+)-permeable member of the vanilloid subgroup of the transient receptor potential (TRP) channels, is activated by cell swelling and moderate heat (>27 degrees C) as well as by diverse chemical compounds including synthetic 4 alpha-phorbol esters, the plant extract bisandrographolide A, and endogenous epoxyeicosatrienoic acids (EETs; 5,6-EET and 8,9-EET). Previous work identified a tyrosine residue located in the first half of putative transmembrane segment 3 (TM3) as a crucial determinant for the activation of TRPV4 by its most specific agonist 4 alpha-phorbol 12,13-didecanoate (4 alpha-PDD), suggesting that 4 alpha-PDD interacts with the channel through its transmembrane segments. To obtain insight in the 4 alpha-PDD-binding site and in the mechanism of ligand-dependent TRPV4 activation, we investigated the consequences of specific point mutations in TM4 on the sensitivity of the channel to different chemical and physical stimuli. Mutations of two hydrophobic residues in the central part of TM4 (Leu(584) and Trp(586)) caused a severe reduction of the sensitivity of the channel to 4 alpha-PDD, bisandrographolide A, and heat, whereas responses to cell swelling, arachidonic acid, and 5,6-EET remained unaffected. In contrast, mutations of two residues in the C-terminal part of TM4 (Tyr(591) and Arg(594)) affected channel activation of TRPV4 by all stimuli, suggesting an involvement in channel gating rather than in interaction with agonists. Based on a comparison of the responses of WT and mutant TRPV4 to 4 alpha-PDD and different 4 alpha-phorbol esters, we conclude that the length of the fatty acid moiety determines the ligand binding affinity and propose a model for the interaction between 4 alpha-phorbol esters and the TM3/4 region of TRPV4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17341586     DOI: 10.1074/jbc.M610485200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Functional TRPV4 channels are expressed in mouse skeletal muscle and can modulate resting Ca2+ influx and muscle fatigue.

Authors:  Bernd W Pritschow; Thom Lange; Joachim Kasch; Christiane Kunert-Keil; Wolfgang Liedtke; Heinrich Brinkmeier
Journal:  Pflugers Arch       Date:  2010-10-06       Impact factor: 3.657

2.  Conserved residues within the putative S4-S5 region serve distinct functions among thermosensitive vanilloid transient receptor potential (TRPV) channels.

Authors:  Stepana Boukalova; Lenka Marsakova; Jan Teisinger; Viktorie Vlachova
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

3.  Discrete control of TRPV4 channel function in the distal nephron by protein kinases A and C.

Authors:  Mykola Mamenko; Oleg L Zaika; Nabila Boukelmoune; Jonathan Berrout; Roger G O'Neil; Oleh Pochynyuk
Journal:  J Biol Chem       Date:  2013-05-24       Impact factor: 5.157

Review 4.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

5.  Ligand stoichiometry of the cold- and menthol-activated channel TRPM8.

Authors:  Annelies Janssens; Thomas Voets
Journal:  J Physiol       Date:  2011-08-30       Impact factor: 5.182

6.  The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells.

Authors:  Daniel A Ryskamp; Paul Witkovsky; Peter Barabas; Wei Huang; Christopher Koehler; Nikolay P Akimov; Suk Hee Lee; Shiwani Chauhan; Wei Xing; René C Rentería; Wolfgang Liedtke; David Krizaj
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

7.  Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.

Authors:  Deborah Krakow; Joris Vriens; Natalia Camacho; Phi Luong; Hannah Deixler; Tara L Funari; Carlos A Bacino; Mira B Irons; Ingrid A Holm; Laurie Sadler; Ericka B Okenfuss; Annelies Janssens; Thomas Voets; David L Rimoin; Ralph S Lachman; Bernd Nilius; Daniel H Cohn
Journal:  Am J Hum Genet       Date:  2009-02-19       Impact factor: 11.025

8.  The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.

Authors:  M S Grace; T Lieu; B Darby; F C Abogadie; N Veldhuis; N W Bunnett; P McIntyre
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

9.  Interdomain interactions control Ca2+-dependent potentiation in the cation channel TRPV4.

Authors:  Rainer Strotmann; Marcus Semtner; Frauke Kepura; Tim D Plant; Torsten Schöneberg
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

10.  Dependence of regulatory volume decrease on transient receptor potential vanilloid 4 (TRPV4) expression in human corneal epithelial cells.

Authors:  Zan Pan; Hua Yang; Stefan Mergler; Hongshan Liu; Souvenir D Tachado; Fan Zhang; Winston W Y Kao; Henry Koziel; Uwe Pleyer; Peter S Reinach
Journal:  Cell Calcium       Date:  2008-10       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.